Jonathan Sessler

Last updated
Jonathan L. Sessler
Jonathan Sessler.jpg
Jonathan L. Sessler
Born (1956-05-20) 20 May 1956 (age 67)
CitizenshipAmerican
EducationMSc at University of California, Berkeley
PhD at Stanford University
Postdoc at Louis Pasteur University
Alma materUniversity of California
Stanford University
Known for
Scientific career
Institutions University of Texas at Austin
Thesis  (1982)
Doctoral advisor James P. Collman [1]

Jonathan Sessler (born 20 May 1956 in Urbana, Illinois) is a professor of chemistry at The University of Texas at Austin. He is notable for his pioneering work on expanded porphyrins and their applications to biology and medicine. He is a co-founder of Pharmacyclics, Inc., a company that works with expanded porphyrins, and Anionics, Inc., which develops anion recognition chemistry. Pharmacyclics was sold to AbbVie for $21 billion in 2015. [2] [3]

Contents

History and career

Sessler received his Bachelor of Science in Chemistry in 1977 from the University of California, Berkeley and his Ph.D. in chemistry in 1982 from Stanford University. He continued as a post-doctoral fellow at L'Université Louis Pasteur, and worked in Kyoto, Japan before becoming an assistant professor of chemistry at The University of Texas at Austin in 1984.

He is a three-time Hodgkin's Lymphoma cancer survivor. He was treated for cancer at Stanford University Medical Center during work on his Ph.D. Discussions with his colleagues regarding possible treatments eventually led to the discovery of so-called "texaphyrin" molecules, named as such due a semblance to the shape of the five-pointed star in the State flag of Texas.,10-Gallon Molecule Stomps Tumors In 1996, Sessler described possible uses of these compounds in medicine in the Proceedings of the National Academy of Sciences journal. He formed a company, Pharamcyclics, Inc., with Dr. Richard A. Miller whom treated him for his cancer. His company,which went public in 1995, licensed the technology behind "texaphyrins" from the university to develop commercial and medical uses for the molecules. The company was later acquired by Bob Duggan in the year 2008 as he became the largest shareholder of the company.

Texaphyrin core Nitrogen superimpose with 5 points of the star featured on the state flag of Texas Texasflag texaphyrin Rahulsoman.jpg
Texaphyrin core Nitrogen superimpose with 5 points of the star featured on the state flag of Texas

Sessler has written extensively, authoring or co-authoring over 600 publications. In addition, he has co-authored two books and edited another two. [5] He holds more than 70 U.S. patents. Dr. Sessler has received many awards and much recognition, as a Sloan Fellow (1999), Fellow of the AAAS (1999), Dreyfus Teacher-Scholar (1999), ACS Cope Scholar (1999), recipient of the JSPS and Alexander von Humboldt Senior Fellowships (1999), and winner of the Izatt-Christensen Award (1999).

Sessler has participated in hosting chemistry circuses on the UT campus.University Events | What Starts Here Changes the World, UT DISCOVERY MAGAZINE v15n4 Science Fun Day photo These circuses are held for different grade levels from elementary to college, and aim to expose students to "fun" aspects of chemistry. Sessler has also lectured on how the disease Porphyria, caused by a deficiency in porphyrins, may be related to the origin of myths about vampires and werewolves.

In 2021, he was elected member of the U. S. National Academy of Sciences. [6]

Related Research Articles

<span class="mw-page-title-main">Dudley R. Herschbach</span> American chemist

Dudley Robert Herschbach is an American chemist at Harvard University. He won the 1986 Nobel Prize in Chemistry jointly with Yuan T. Lee and John C. Polanyi "for their contributions concerning the dynamics of chemical elementary processes". Herschbach and Lee specifically worked with molecular beams, performing crossed molecular beam experiments that enabled a detailed molecular-level understanding of many elementary reaction processes. Herschbach is a member of the Board of Sponsors of the Bulletin of the Atomic Scientists.

The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and state of Texas.

<span class="mw-page-title-main">Henry F. Schaefer III</span> American theoretical chemist

Henry Frederick "Fritz" Schaefer III is a computational and theoretical chemist. He is one of the most highly cited chemists in the world, with a Thomson Reuters H-Index of 121 as of 2020. He is the Graham Perdue Professor of Chemistry and Director of the Center for Computational Chemistry at the University of Georgia. Before becoming professor at Georgia he was professor at University of California, Berkeley and in 2004, he became Professor of Chemistry Emeritus, at UC Berkeley

Stuart L. Schreiber is a scientist at Harvard University and co-founder of the Broad Institute. He has been active in chemical biology, especially the use of small molecules as probes of biology and medicine. Small molecules are the molecules of life most associated with dynamic information flow; these work in concert with the macromolecules that are the basis for inherited information flow.

<span class="mw-page-title-main">Carolyn Bertozzi</span> American chemist (born 1966)

Carolyn Ruth Bertozzi is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory.

<span class="mw-page-title-main">Stephen F. Martin</span>

Stephen F. Martin is an American chemist and professor of chemistry at The University of Texas at Austin. He is the M. June and J. Virgil Waggoner Regents Chair in Chemistry.

Harden M. McConnell was an American physical chemist. His many awards included the National Medal of Science and the Wolf Prize, and he was elected to the National Academy of Science."

<span class="mw-page-title-main">Allen J. Bard</span> American electrochemist

Allen Joseph Bard is an American chemist. He is the Hackerman-Welch Regents Chair Professor and director of the Center for Electrochemistry at the University of Texas at Austin. Bard is considered a "father of modern electrochemistry" for his innovative work developing the scanning electrochemical microscope, his co-discovery of electrochemiluminescence, his key contributions to photoelectrochemistry of semiconductor electrodes, and co-authoring a seminal textbook.

Paul Frank Barbara was an American chemist. His research interests focused on the understanding of the molecular structure and dynamics of complex chemical systems, including organic semi-conductors for photovoltaic applications, proton and electron transfer reactions, the hydrated electron and intermediates in the reverse transcription mechanism of HIV-1. His laboratory developed and applied novel ultrafast and single molecule spectroscopies to study the complexity of these chemical system.

<span class="mw-page-title-main">Thomas C. Südhof</span> German-American biochemist

Thomas Christian Südhof, ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.

<span class="mw-page-title-main">Eric N. Olson</span> American molecular biologist

Eric Newell Olson is an American molecular biologist. He is professor and chair of the Department of Molecular Biology at the University of Texas Southwestern Medical Center in Dallas, where he also holds the Robert A. Welch Distinguished Chair in Science, the Annie and Willie Nelson Professorship in Stem Cell Research, and the Pogue Distinguished Chair in Research on Cardiac Birth Defects.

<span class="mw-page-title-main">Ibrutinib</span> Medication used in cancer treatment

Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that inhibits B-cell proliferation and survival by irreversibly binding the protein Bruton's tyrosine kinase (BTK). Blocking BTK inhibits the B-cell receptor pathway, which is often aberrantly active in B cell cancers. Ibrutinib is therefore used to treat such cancers, including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. Ibrutinib also binds to C-terminal Src Kinases. These are off-target receptors for the BTK inhibitor. Ibrutinib binds to these receptors and inhibits the kinase from promoting cell differentiation and growth. This leads to many different side effects like left atrial enlargement and atrial fibrillation during the treatment of Chronic Lymphocytic Leukemia.

<span class="mw-page-title-main">Andrew Bruce Holmes</span> Australian and British research chemist and professor

Andrew Bruce Holmes is an Australian and British senior research chemist and professor at the Bio21 Institute, Melbourne, Australia, and the past President of the Australian Academy of Science. His research interests lie in the synthesis of biologically-active natural products and optoelectronic polymers.

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira (adalimumab), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis.

Livia Schiavinato Eberlin is a Brazilian analytical chemist who won a MacArthur "Genius" Fellowship for her research on the use of mass spectrometry to detect cancerous tissue.

Bruce C. Gibb is a professor of chemistry at Tulane University. He is notable for his work in aqueous supramolecular chemistry, with particular emphasis on self-assembly leading to compartmentalization, and contributing to fundamental understandings of the hydrophobic effect and Hofmeister effect

<span class="mw-page-title-main">Atsuhiro Osuka</span>

Atsuhiro Osuka is a research professor of organic chemistry in the Department of Chemistry, Graduate School of Science, Kyoto University (Japan). He is recognized in the fields of porphyrinoid chemistry for his works in extended π-electron systems and its tunable aromatic behaviors.

Jason Ben Shear is an American chemist and expert in biomaterials and bioengineering. He is currently Professor of Chemistry at the University of Texas at Austin. Shear has been considered one of the pioneers of two-photon photolithography.

Amanda E. Hargrove is a chemist and professor at Duke University. Hargrove is also the editor-in-chief of Medicinal Research Reviews, and a member of the Scientific Advisory Board of Arrakis Therapeutics. At Duke University, Hargrove directs an interdisciplinary research program in chemical biology that focuses on harnessing the specific interactions between small molecules and RNA, and using those RNA-small molecule interactions to probe the structure, and function of RNA. The long-term goal of the group's research is to identify specific molecule-RNA interactions that may have therapeutic potential in the treatment of viral infection and human disease. She has received numerous awards for her scientific research, teaching, and service in support of diversity, equity, and inclusion.

References

  1. "Jonathan L Sessler". utexas.edu. UT Experts.
  2. "AbbVie Completes Acquisition of Pharmacyclics | AbbVie Newsroom". news.abbvie.com. Retrieved 2018-07-11.
  3. "AbbVie buys cancer drugmaker Pharmacyclics in $21B deal". USA TODAY. Retrieved 2018-07-11.
  4. Preihs, Christian; Arambula, Jonathan F.; Magda, Darren; Jeong, Heeyeong; Yoo, Dongwon; Cheon, Jinwoo; Siddik, Zahid H.; Sessler, Jonathan L. (April 4, 2013). "Recent Developments in Texaphyrin Chemistry and Drug Discovery". Inorg. Chem. 52 (21): 12184–12192. doi:10.1021/ic400226g. PMC   3963820 . PMID   23557113.
  5. "Archived copy" (PDF). Archived from the original (PDF) on 2019-05-31. Retrieved 2019-05-31.{{cite web}}: CS1 maint: archived copy as title (link)
  6. "News from the National Academy of Sciences". April 26, 2021. Retrieved July 5, 2021. Newly elected members and their affiliations at the time of election are: … Sessler, Jonathan L.; R.P. Doherty Jr.-Welch Regents Chair in Chemistry and professor, department of chemistry, University of Texas, Austin, entry in member directory: "Member Directory". National Academy of Sciences. Retrieved July 5, 2021.